Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

489
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
489
Analgesia and Pain Management01:25

Analgesia and Pain Management

902
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
902
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

438
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
438
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

2.2K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
2.2K
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

266
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
266
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

829
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
829

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bridging the Gap: Implementing the 2024 National Cancer Control Programme (NCCP) Melanoma Imaging Guidelines in Real-World Practice.

Irish medical journal·2026
Same author

"They just looked at me like I was human": The experiences of parenting women and providers with substance use disorder treatment.

Journal of substance use and addiction treatment·2023
Same author

Protocol for the implementation of a statewide mobile addiction program.

Journal of comparative effectiveness research·2023
Same author

A systematic literature review of the management, oncological outcomes and psychosocial implications of male breast cancer.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2022
Same author

Not just substance use: the critical gap in nutritional interventions for pregnant women with opioid use disorders.

Public health·2019
Same author

COMPETITIVE HIERARCHIES IN LABORATORY DROSOPHILA.

Evolution; international journal of organic evolution·2017
Same journal

Multiple Output Gaussian Process Model for Predicting Low Birth Weight in Medellín, Colombia: An Alternative to Conventional Machine Learning Models.

Maternal and child health journal·2026
Same journal

Baby-Feed Pilot Trial for Improving Diet and Weight Gain in Infants and Toddlers.

Maternal and child health journal·2026
Same journal

Association of Food Insecurity with Mental Health and Clinical Outcomes Among Women Living with HIV/AIDS: A Cross-Sectional Study of Southwestern Iran.

Maternal and child health journal·2026
Same journal

Awareness and Attitudes of Health Professionals on Endocrine Disruptors in Pregnancy.

Maternal and child health journal·2026
Same journal

Differences in Maternal Outcomes Among American Indian/Alaska Native and White Women with Hypertensive Disorder of Pregnancy in a Rural State.

Maternal and child health journal·2026
Same journal

Perceived Clinician Autonomy Support Before and After the COVID-19 Pandemic Onset in a Pregnancy Cohort.

Maternal and child health journal·2026
See all related articles

Related Experiment Video

Updated: Oct 6, 2025

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

383

Implementation of a Prenatal Naloxone Distribution Program to Decrease Maternal Mortality from Opioid Overdose.

M Duska1, D Goodman2,3

  • 1The Dartmouth Institute for Health Policy and Clinical Practice, 74 College St, Hanover, NH, 03755, USA. marykateduska@gmail.com.

Maternal and Child Health Journal
|January 14, 2022
PubMed
Summary
This summary is machine-generated.

A New Hampshire Ob/Gyn clinic implemented a naloxone distribution program to combat rising maternal mortality from opioid overdoses. The program successfully maintained patient screening and discussions despite COVID-19 challenges.

Keywords:
Maternal mortalityNaloxoneNarcanOverdoseQuality improvement

More Related Videos

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

86.6K
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.1K

Related Experiment Videos

Last Updated: Oct 6, 2025

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

383
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

86.6K
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.1K

Area of Science:

  • Obstetrics and Gynecology
  • Public Health
  • Addiction Medicine

Background:

  • Maternal mortality rates are rising in the US, with opioid overdoses being a significant factor.
  • New Hampshire faces a severe crisis, with 50% of maternal deaths linked to drug overdoses (2016-2017).
  • This study addresses the critical need for interventions in maternal care.

Purpose of the Study:

  • To report the implementation of a point-of-care naloxone distribution program in an Ob/Gyn clinic in New Hampshire.
  • To provide a framework for other clinics to adopt similar naloxone programs.
  • To improve outcomes for vulnerable perinatal populations affected by opioid use.

Main Methods:

  • Tracked naloxone distribution and calculated screening/discussion proportions.
  • Monitored program implementation using statistical process control charts.
  • Collected qualitative patient and provider feedback on the program's reception.

Main Results:

  • 12 doses of naloxone distributed since April 2020.
  • Screening rates remained stable at 73% (moving average), despite pandemic challenges.
  • Patient-provider discussions averaged 51% (moving average) and were well-received.

Conclusions:

  • The implemented naloxone program serves as a model for other Ob/Gyn clinics.
  • While long-term impact on maternal mortality is pending, the program is a vital intervention.
  • Naloxone programs in obstetrics enhance care for at-risk perinatal patients.